Search

Your search keyword '"S. BAU"' showing total 53 results

Search Constraints

Start Over You searched for: Author "S. BAU" Remove constraint Author: "S. BAU" Database MEDLINE Remove constraint Database: MEDLINE
53 results on '"S. BAU"'

Search Results

1. Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist.

2. The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier.

3. Size-distribution and driving factors of aerosol oxidative potential in rural kitchen microenvironments of northeastern India.

5. Strategies to Assess Occupational Exposure to Airborne Nanoparticles: Systematic Review and Recommendations.

6. Understanding population exposure to size-segregated aerosol and associated trace elements during residential cooking in northeastern India: Implications for disease burden and health risk.

7. Towards a surface metric to measure the dustiness of nanomaterial powders.

8. Retained particle surface area dose drives inflammation in rat lungs following acute, subacute, and subchronic inhalation of nanomaterials.

9. What does ergonomics have to do with nanotechnologies? A case study.

10. Seasonal Evolution of Size-Segregated Particulate Mercury in the Atmospheric Aerosol Over Terra Nova Bay, Antarctica.

11. Characterizing particle emissions from a direct energy deposition additive manufacturing process and associated occupational exposure to airborne particles.

12. Pulmonary toxicity of two different multi-walled carbon nanotubes in rat: Comparison between intratracheal instillation and inhalation exposure.

13. Toward an operational methodology to identify industrial-scaled nanomaterial powders with the volume specific surface area criterion.

14. Managing uncertainty in movement knowledge for environmental decisions.

15. Diffuse pulmonary small nodular and patchy infiltrates on chest X-ray with hemoptysis: TB or not TB?-a call for scale up of respiratory medicine services in African TB high burden countries: a case of idiopathic pulmonary hemosiderosis.

16. Combining NSAM and CPC concentrations to determine airborne nanoparticle count median diameter: Application to various laboratory and workplace aerosols.

17. Inter-comparison of personal monitors for nanoparticles exposure at workplaces and in the environment.

18. Sampling Efficiency and Performance of Selected Thoracic Aerosol Samplers.

19. Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States.

20. Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use.

21. Guidelines for Using Movement Science to Inform Biodiversity Policy.

22. Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis.

23. A laboratory study of the performance of the handheld diffusion size classifier (DiSCmini) for various aerosols in the 15-400 nm range.

24. Boceprevir in liver transplant recipients.

25. Viral breakthrough is associated with resistance using direct acting agents in patients treated for chronic hepatitis C infection.

26. Evaluation of the diffusion size classifier (meDiSC) for the real-time measurement of particle size and number concentration of nanoaerosols in the range 20-700 nm.

27. Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.

28. Targeted next-generation sequencing by specific capture of multiple genomic loci using low-volume microfluidic DNA arrays.

29. Three-dimensional volume sonographic study of fetal anatomy: intraobserver reproducibility and effect of examiner experience.

30. Co-option of a default secretory pathway for plant immune responses.

31. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?

32. Clinical usefulness of 3-dimensional sonography and power Doppler angiography for diagnosis of endometrial carcinoma.

33. Prediction of ovarian response and IVF/ICSI outcome by three-dimensional ultrasonography and power Doppler angiography.

35. Assessment of the ovarian volume, number and volume of follicles and ovarian vascularity by three-dimensional ultrasonography and power Doppler angiography on the HCG day to predict the outcome in IVF/ICSI cycles.

36. Endometrial volume and vascularity measurements by transvaginal three-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria: intraobserver reproducibility.

37. Assessment of placental vascularization by three-dimensional power Doppler "vascular biopsy" in normal pregnancies.

38. Intraobserver and interobserver reproducibility of ovarian volume, antral follicle count, and vascularity indices obtained with transvaginal 3-dimensional ultrasonography, power Doppler angiography, and the virtual organ computer-aided analysis imaging program.

39. Endometrial volume and vascularity measurements by transvaginal 3-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria: an interobserver reproducibility study.

40. Reproducibility of the study of placental vascularization by three-dimensional power Doppler.

41. SNARE-protein-mediated disease resistance at the plant cell wall.

42. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy.

43. Stenting for obstructing colorectal malignancy: an interim or definitive procedure.

44. Doppler study of arterial and venous intraovarian blood flow in stimulated cycles.

45. B-mode, utero-ovarian and intratumoural transvaginal colour Doppler ultrasonography for differential diagnosis of ovarian tumours.

46. Is a standard regime for anticoagulation with heparin in unstable angina adequate?

47. Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema.

48. Color Doppler sonographic assessment of placental circulation in the first trimester of normal pregnancy.

49. [Management of dysplasias of the uterine cervix].

50. [Histogenesis and pathological anatomy of dysplasias of the uterine cervix].

Catalog

Books, media, physical & digital resources